Source: Virtual Congress 2020 – Lung transplantation in the era of new drugs
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Tomassetti (Florence, Italy). New antifibrotic drugs: will interstitial diseases patients still need lung transplantation?. Virtual Congress 2020 – Lung transplantation in the era of new drugs

Member's Comments

No comment yet.

Related content which might interest you: Safety of antifibrotic drugs in idiopathic pulmonary fibrosis patients awaiting lung transplantation Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Lung transplantation for pulmonary hypertension: the impact of new drug therapies Source: Annual Congress 2004 - Lung transplantation: new insights in advanced lung disease and new drug developments - do they impact on selection criteria? Year: 2004 Impact of antifibrotic drugs in lung transplantation Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019 Lung transplantation: the ideal treatment for diffuse disease? Source: Annual Congress 2006 - Up to date management of bronchiectasis Year: 2006 Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease? Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Medical complications of lung transplantation Source: Eur Respir J 2004; 23: 334-342 Year: 2004 Interstitial lung diseases and transplantation - how to choose the best candidate? Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward? Year: 2021 Late Breaking Abstract - The outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 What’s new in interstitial lung diseases in children? Source: Virtual Congress 2021 – Paediatric year in review Year: 2021 Antithrombotics in idiopathic pulmonary fibrosis patients with concomitant antifibrotic therapy: a single centre real world experience Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 The need for lung transplantation in cystic fibrosis (CF) in the era of new treatment Source: Virtual Congress 2020 – Lung transplantation in the era of new drugs Year: 2020 New issues in lung transplantation for pulmonary hypertension Source: Virtual Congress 2020 – Lung transplantation in the era of new drugs Year: 2020 New indications for lung transplantation Source: Annual Congress 2013 –ME12 New indications for lung transplantation Year: 2013 Update on lung transplantation: programmes, patients and prospects Source: Eur Respir Rev 2012 21: 271-305 Year: 2012 Current and future therapeutic approaches in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: 693-703 Year: 2005 Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Infectious complications after lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=193 Year: 2003